Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694600 · ClinicalTrials.gov registry record
Clinical Trial Multi-analyte Blood Test
A clinical trial, sponsored by Helio Genomics.
- Active
- Registry status
- 1,900
- Enrollment target
NCT03694600 is a clinical trial that is active but no longer recruiting, run by Helio Genomics. The registered enrollment target is 1,900 participants.
The verdict
NCT03694600 is active but no longer recruiting, sponsored by Helio Genomics.
- ACTIVE NOT RECRUITING
- Registry status
- 1,900 participants
- Enrollment target
Study Summary
This is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high risk for HCC due to liver cirrhosis.
Interventions
- DIAGNOSTIC_TEST Multi-analyte blood Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,900 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2027-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03694600
The ClinicalTrials.gov registry entry for NCT03694600 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helio Genomics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multi-analyte blood Test is the first listed.
NCT03694600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03694600 about?
NCT03694600 is a clinical study titled "Clinical Trial Multi-analyte Blood Test". This is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high risk for HCC due to liver cirrhosis.
What is the current status of trial NCT03694600?
This trial is currently active not recruiting. The enrollment target is 1,900 participants. The study started on 2019-02-04. Estimated completion is 2027-12-30.
What interventions are being tested in trial NCT03694600?
The interventions under investigation include: Multi-analyte blood Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03694600?
This trial is sponsored by Helio Genomics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.